Cargando…

MicroRNA-766 inhibits papillary thyroid cancer progression by directly targeting insulin receptor substrate 2 and regulating the PI3K/Akt pathway

Detalles Bibliográficos
Autores principales:	Zhao, Jianjie, Li, Zhirong, Chen, Yi, Zhang, Shu, Guo, Lingji, Gao, Bo, Jiang, Yan, Tian, Wuguo, Hao, Shuai, Zhang, Xiaohua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2022
Materias:	Retraction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170351/ https://www.ncbi.nlm.nih.gov/pubmed/35642668 http://dx.doi.org/10.3892/ijo.2022.5376

Ejemplares similares

MicroRNA-497 inhibits cellular proliferation, migration and invasion of papillary thyroid cancer by directly targeting AKT3
por: Zhuang, Juhua, et al.
Publicado: (2022)

MicroRNA-509 targets PAX6 to inhibit cell proliferation and invasion in papillary thyroid carcinoma
por: Zhang, Shuilong, et al.
Publicado: (2022)

MicroRNA-139 targets fibronectin 1 to inhibit papillary thyroid carcinoma progression
por: Ye, Ying, et al.
Publicado: (2022)

MicroRNA-448 inhibits the progression of retinoblastoma by directly targeting ROCK1 and regulating PI3K/AKT signalling pathway
por: Wu, Shen, et al.
Publicado: (2022)

MicroRNA-936 inhibits the malignant phenotype of retinoblastoma by directly targeting HDAC9 and deactivating the PI3K/AKT pathway
por: Xu, Lishuai, et al.
Publicado: (2022)

Lobaplatin inhibits breast cancer progression, cell proliferation while it induces cell apoptosis by downregulating MTDH expression
por: Tian, Wuguo, et al.
Publicado: (2018)

Retraction: MicroRNA-367 promotes progression of hepatocellular carcinoma through PTEN/PI3K/AKT signaling pathway
Publicado: (2020)

MicroRNA-761 Targets FGFR1 to Suppress the Malignancy of Osteosarcoma by Deactivating PI3K/Akt Pathway [Retraction]
Publicado: (2021)

[Retracted] MicroRNA‑1297 contributes to tumor growth of human breast cancer by targeting PTEN/PI3K/AKT signaling
por: Liu, Chao, et al.
Publicado: (2023)

Silencing NOB1 enhances doxorubicin antitumor activity of the papillary thyroid carcinoma in vitro and in vivo
por: Liu, Jia, et al.
Publicado: (2022)

Fangchinoline targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901 cells
por: Tian, Feng, et al.
Publicado: (2023)

[Retracted] MicroRNA‑744 suppresses cell proliferation and invasion of papillary thyroid cancer by directly targeting NOB1
por: Liu, Haixia, et al.
Publicado: (2023)

MicroRNA-21 increases cell viability and suppresses cellular apoptosis in non-small cell lung cancer by regulating the PI3K/Akt signaling pathway
por: Wang, Tao, et al.
Publicado: (2021)

MicroRNA-936 Targets FGF2 to Inhibit Epithelial Ovarian Cancer Aggressiveness by Deactivating the PI3K/Akt Pathway [Retraction]
Publicado: (2021)

MicroRNA-511 inhibits malignant behaviors of breast cancer by directly targeting SOX9 and regulating the PI3K/Akt pathway
por: Zhao, Yuying, et al.
Publicado: (2022)

microRNA-564 Inhibits the Aggressive Phenotypes of Papillary Thyroid Cancer by Directly Targeting Astrocyte-Elevated Gene-1 [Retraction]
Publicado: (2021)

MicroRNA-138 suppresses cell proliferation in laryngeal squamous cell carcinoma via inhibiting EZH2 and PI3K/AKT signaling
por: Si, Fengzhi, et al.
Publicado: (2021)

Retracted: Effect of Eriodictyol on Retinoblastoma via the PI3K/Akt Pathway
por: Healthcare Engineering, Journal of
Publicado: (2023)

MicroRNA-126 inhibits the migration and invasion of endometrial cancer cells by targeting insulin receptor substrate 1
por: Zhao, Xiumin, et al.
Publicado: (2021)

microRNA-944 Inhibits the Malignancy of Hepatocellular Carcinoma by Directly Targeting IGF-1R and Deactivating the PI3K/Akt Signaling Pathway [Retraction]
Publicado: (2021)

MicroRNA-107 inhibits tumor growth and metastasis by targeting the BDNF-mediated PI3K/AKT pathway in human non-small lung cancer
por: Xia, Huan, et al.
Publicado: (2021)

MicroRNA-21 Contributes to Cutaneous Squamous Cell Carcinoma Progression via Mediating TIMP3/PI3K/AKT Signaling Axis [Retraction]
Publicado: (2023)

Retraction Notice to: Circular RNA Profiling Reveals Exosomal circ_0006156 as a Novel Biomarker in Papillary Thyroid Cancer
por: Wu, Guojun, et al.
Publicado: (2022)

[Retracted] SIRT1 promotes tumorigenesis of hepatocellular carcinoma through PI3K/PTEN/AKT signaling
por: Wang, Hanning, et al.
Publicado: (2023)

microRNA-605 Directly Targets SOX9 to Alleviate the Aggressive Phenotypes of Glioblastoma Multiforme Cell Lines by Deactivating the PI3K/Akt Pathway [Retraction]
Publicado: (2021)

MicroRNA-939-5p directly targets IGF-1R to inhibit the aggressive phenotypes of osteosarcoma through deactivating the PI3K/Akt pathway
por: Zhao, Xiwu, et al.
Publicado: (2022)

Retracted: MicroRNA-517c Functions as a Tumor Suppressor in Hepatocellular Carcinoma via Downregulation of KPNA2 and Inhibition of PI3K/AKT Pathway
por: Engineering, Journal of Healthcare
Publicado: (2023)

miR-126 inhibits papillary thyroid carcinoma growth by targeting LRP6
por: Wen, Qiang, et al.
Publicado: (2021)

[Retracted] Deoxypodophyllotoxin inhibits cell viability and invasion by blocking the PI3K/Akt signaling pathway in human glioblastoma cells
por: Wang, Wei, et al.
Publicado: (2023)

MicroRNA-675 Directly Targets MAPK1 to Suppress the Oncogenicity of Papillary Thyroid Cancer and is Sponged by Long Non-Coding RNA RMRP [Retraction]
Publicado: (2021)

The key role of microRNA-766 in the cancer development
por: Gupta, Jitendra, et al.
Publicado: (2023)

Retraction: MicroRNA-497 inhibits thyroid cancer tumor growth and invasion by suppressing BDNF
por: Wang, Peisong, et al.
Publicado: (2022)

Retracted: Parthenolide Inhibits the Proliferation of MDA-T32 Papillary Thyroid Carcinoma Cells In Vitro and in Mouse Tumor Xenografts and Activates Autophagy and Apoptosis by Downregulation of the Mammalian Target of Rapamycin (mTOR)/PI3K/AKT Signaling Pathway
por: Li, Chao, et al.
Publicado: (2021)

Retraction statement: MicroRNA‐21 promotes glioma cell proliferation and inhibits senescence and apoptosis by targeting SPRY1 via the PTEN/PI3K/AKT signaling pathway
Publicado: (2021)

Paclitaxel increases the sensitivity of lung cancer cells to lobaplatin via PI3K/Akt pathway
por: Ma, Dongjie, et al.
Publicado: (2021)

Retracted: PTPN18 Stimulates the Development of Ovarian Cancer by Activating the PI3K/AKT Signaling
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Chronic alcohol exposure exacerbates inflammation and triggers pancreatic acinar-to-ductal metaplasia through PI3K/Akt/IKK
por: Huang, Xin, et al.
Publicado: (2023)

Retracted: Prescription of Sageretia hamosa Brongn Relieved Goiter through Promoted Apoptosis of Thyroid Cells via miR-511-3p and PTEN/PI3K/Akt Pathway
por: Healthcare Engineering, Journal of
Publicado: (2023)

Retraction Note: Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway
por: Fu, Xiao, et al.
Publicado: (2023)

Retracted: TILRR Aggravates Sepsis-Induced Acute Lung Injury by Suppressing the PI3K/Akt Pathway
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_53k8gc8d8flaggqddvaeu3sojs